NEW YORK (GenomeWeb News) – Laboratory Corporation of America today reported that its fourth-quarter revenues increased 3 percent, beating analyst expectations, as disruptions due to inclement weather hit the firm's bottom line.

The Burlington, NC-based clinical lab firm brought in total revenues of $1.41 billion for the three months ended Dec. 31, exceeding Wall Street's consensus expectation of $1.39 billion and above Q4 2011 revenues of $1.37 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

The New York Times editorial board weighs in on scientific research misconduct.